Innovation in Carotid Artery Stenting
Patients with carotid artery narrowing had been limited to endarterectomy or stenting, however a new approach allows for comparable results with less risk.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Kenneth Rosenfield, MD, is the Section Head for Vascular Medicine and Intervention and Chairs the Acute Myocardial Infarction(STEMI)Committee for the cardiac cath lab. He is a national leader in treatment of Carotid, Kidney, and Leg artery disease.
Dr. Rosenfield is the Section Head for Vascular Medicine and Intervention, who specializes in complex cardiac and vascular interventions and directs the program for treatment of acute myocardial infarction (STEMI) in the cardiac catheterization laboratories. He has spearheaded the development of less-invasive therapies for patients with coronary and vascular disease, both at MGH and nationally, including treatment of Carotid, Kidney, and Leg artery narrowing using stents and other novel devices.
Clinical Interests:
Treats:
Interventional Cardiology Associates
55 Fruit Street
Boston, MA 02114
Phone: 617-726-2256
Phone: 617-724-1935
Fax: 617-726-3971
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Rosenfield has served as national principle investigator (PI) for numerous clinical trials
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
Patients with carotid artery narrowing had been limited to endarterectomy or stenting, however a new approach allows for comparable results with less risk.
Pulmonary embolism calls for a coordinated clinical approach. A new paradigm for care.